Exosomal miRNAs and isomiRs: potential biomarkers for type 2 diabetes mellitus
Precision Clinical Medicine · 24.07.2024 · 7 (3)
DOI: 10.1093/pcmedi/pbae021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Precision Clinical Medicine, online erschienen am 20.09.2024. Verfasst von Yong Ling Sou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biomedical Science, Faculty of Science and Engineering, University of Nottingham Malaysia, Semenyih, Selangor 43500, Malaysia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science, Technology and Innovation, Malaysia, University of Nottingham Malaysia Campus.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) is a metabolic disease that is characterized by chronic hyperglycaemia. MicroRNAs (miRNAs) are single-stranded, small non-coding RNAs that play important roles in post-transcriptional gene regulation. They are negative regulators of their target messenger RNAs (mRNAs), in which they bind either to inhibit mRNA translation, or to induce mRNA decay. Similar to proteins, miRNAs exist in different isoforms (isomiRs). miRNAs and isomiRs are selectively loaded into small extracellular vesicles, such as the exosomes, to protect them from RNase degradation. In T2DM, exosomal miRNAs produced by different cell types are transported among the primary sites of insulin action. These interorgan crosstalk regulate various T2DM-associated pathways such as adipocyte inflammation, insulin signalling, and β cells dysfunction among many others. In this review, we first focus on the mechanism of exosome biogenesis, followed by miRNA biogenesis and isomiR formation. Next, we discuss the roles of exosomal miRNAs and isomiRs in the development of T2DM and provide evidence from clinical studies to support their potential roles as T2DM biomarkers. Lastly, we highlight the use of exosomal miRNAs and isomiRs in personalized medicine, as well as addressing the current challenges and future opportunities in this field. This review summarizes how research on exosomal miRNAs and isomiRs has developed from the very basic to clinical applications, with the goal of advancing towards the era of personalized medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biomedical Science, Faculty of Science and Engineering, University of Nottingham Malaysia, Semenyih, Selangor 43500, Malaysia.
- Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA.
- Department of Biological Sciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi, Selangor 43600, Malaysia.
- Department of Pharmacology, University of Malaya, Kuala Lumpur 50603, Malaysia.
ORCID-Profile: Yuh-Fen Pung
Förderung
- Ministry of Science, Technology and Innovation, Malaysia
- University of Nottingham Malaysia Campus
Zitieren
APA
Sou, Y. L., Chilian, W. M., Ratnam, W., Zain, S. M., Syed Abdul Kadir, S. Z., Pan, Y., & Pung, Y. F. (2024). Exosomal miRNAs and isomiRs: potential biomarkers for type 2 diabetes mellitus. Precision Clinical Medicine, 7(3). https://doi.org/10.1093/pcmedi/pbae021
Vancouver
Sou YL, Chilian WM, Ratnam W, Zain SM, Syed Abdul Kadir SZ, Pan Y, et al. Exosomal miRNAs and isomiRs: potential biomarkers for type 2 diabetes mellitus. Precision Clinical Medicine. 2024;7(3). doi:10.1093/pcmedi/pbae021
BibTeX
@article{Sou2024,
author = {Sou, Yong Ling and Chilian, William M and Ratnam, Wickneswari and Zain, Shamsul Mohd and Syed Abdul Kadir, Sharifah Zamiah and Pan, Yan and Pung, Yuh-Fen},
title = {Exosomal miRNAs and isomiRs: potential biomarkers for type 2 diabetes mellitus},
journal = {Precision Clinical Medicine},
year = {2024},
volume = {7},
number = {3},
doi = {10.1093/pcmedi/pbae021}
}
EUVIMED